Calithera Biosciences Inc (NASDAQ:CALA)
| 2.32 Delayed Data As of 3:59pm ET |  +0.035 / +1.54%Today’s Change | 1.87 Today|||52-Week Range 6.19 | -52.85% Year-to-Date |
Latest CALA News | Press Releases
No recent news for Calithera Biosciences Inc.
Today’s Trading
| Previous close | 2.28 |
| Today’s open | 2.29 |
| Day’s range | 2.22 - 2.34 |
| Volume | 15,330 |
| Average volume (3 months) | 997,613 |
| Market cap | $168.8M |
Data as of 3:59pm ET, 06/14/2021
Growth & Valuation
| Earnings growth (last year) | +31.03% |
| Earnings growth (this year) | +27.96% |
| Earnings growth (next 5 years) | +75.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CFRXContraFect Corp | -0.09 | -2.10% |
| EVGNEvogene Ltd | +0.05 | +1.37% |
| IFRXInflarx NV | +0.22 | +7.14% |
| YMTXYumanity Therapeutic... | -0.07 | -0.43% |
Data as of 5:34pm ET, 06/14/2021
Financials
| Next reporting date | August 10, 2021 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$90.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
